Industry Newsgenetic targetscardiovasculartenaya therapeuticsalnylam pharmaceuticals
Tenaya Therapeutics Enters Collaboration With Alnylam To Identify Targets
|
4.9
Tenaya Therapeutics and Alnylam Pharmaceuticals enter a research collaboration to identify and validate novel genetic targets for cardiovascular disease therapeutics. The agreement combines Tenaya’s expertise in identification and validation, according to the RSS description.
Scoring Rationale
Moderate industry relevance and partnership signal; RSS-only limited details reduce depth, confirmation, and overall certainty.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
